Detail Infos AhRi 2416964/20201 Aryl (First-in-human Studie): Orale Monotherapie mit Aryl Hydrocarbon Receptor inhibitor BAY 2416964 (protein involved in immune cell reaction to tumor cells)


Universitätsklinikum Heidelberg ID: 740